Transforming growth factor-β1 and tumor necrosis factor-α are associated with clinical severity and airflow limitation of copd in an additive manner

Lung

Volumn 192, Issue 1, 2014, Pages 95-102

  Chiang, Chi Huei ^a,b,c   Chuang, Chiao Hui ^a   Liu, Shiou Ling ^a  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

Author keywords

Chronic obstructive pulmonary disease; Gene polymorphism; Phenotype; Transforming growth factor 1; Tumor necrosis factor

Indexed keywords

AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; FORCED EXPIRATORY VOLUME; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUNG; MIDDLE AGED; PHENOTYPE; POLYMORPHISM, GENETIC; PREDICTIVE VALUE OF TESTS; PROMOTER REGIONS, GENETIC; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY FUNCTION TESTS; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TOMOGRAPHY, X-RAY COMPUTED; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR-ALPHA; VITAL CAPACITY;

EID: 84894079858     PISSN: 03412040     EISSN: 14321750     Source Type: Journal    
DOI: 10.1007/s00408-013-9520-2     Document Type: Article

References (28)

1. Barnes PJ (2008) The cytokine network in asthma and chronic obstructive pulmonary disease. J Clin Invest 118:3546-3556
2. Global Initiative for chronic obstructive lung disease: global strategy for the diagnosis, management and prevention of COPD. 2010. Available at http://www.goldcopd.com/. Accessed Aug 2011
3. Han MK, Agusti A, Calverley PM, Celli BR, Criner G, Curtis JL et al (2010) Chronic obstructive pulmonary disease phenotypes: the future of COPD. Am J Respir Crit Care Med 182:598-604
4. Barnes PJ, Chowdhury B, Kharitonov SA, Magnussen H, Page CP, Postma D et al (2006) Pulmonary biomarkers in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 174:6-14
5. Stockley RA (2007) Biomarkers in COPD: time for a deep breath. Thorax 62:657-660
6. Sin DD, Vestbo J (2009) Biomarkers in chronic obstructive pulmonary disease. Proc Am Thorac Soc 6:543-545
7. Jones PW, Agusti AG (2006) Outcomes and markers in the assessment of chronic obstructive pulmonary disease. Eur Respir J 27:822-832
8. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, Mullerova H et al (2007) Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 62:595-601
9. Pelegrino NR, Tanni SE, Amaral RA, Angeleli AY, Correa C, Godoy I (2012) Effects of active smoking on airway and systemic inflammation profiles in patients with chronic obstructive pulmonary disease. Am J Med Sci 345(6):440-445
10. Sethi S, Mahler DA, Marcus P, Owen CA, Yawn B, Rennard S (2012) Inflammation in COPD: implications for management. Am J Med 125:1162-1170
11. Gan WQ, Man SFP, Senthilselvan A, Sin DD (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59:574-580
12. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M et al (2001) Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1476-1483
13. Soltani A, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH (2012) Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers. PLoS ONE 7:e39736. doi: 10.1371/journal.pone.0039736
14. Gingo MR, Silveira LJ, Miller YE, Friedlander AL, Cosgrove GP, Chan ED et al (2008) Tumour necrosis factor gene polymorphisms are associated with COPD. Eur Respir J 31:1005-1012
15. Chierakul N, Wongwisutikul P, Vejbaesya S, Chotvilaiwan K (2005) Tumor necrosis factor-alpha gene promoter polymorphism is not associated with smoking-related COPD in Thailand. Respirology 10:36-39
16. Hsieh MH, Chong IW, Hwang JJ, Lee CH, Ho CK, Yu ML et al (2008) Lack of associations between several polymorphisms in cytokine genes and the risk of chronic obstructive pulmonary diseases in Taiwan. Kaohsiung J Med Sci 24:126-137
17. Zhang L, Chang WW, Ding H, Su H, Wang HY (2011) Transforming growth factor-β1 polymorphisms and chronic obstructive pulmonary disease: a meta-analysis. Int J Tuberc Lung Dis 15:1301-1307
18. Ito M, Hanaoka M, Droma Y, Hatayama O, Sato E, Katsuyama Y et al (2008) The association of transforming growth factor beta 1 gene polymorphisms with the emphysema phenotype of COPD in Japanese. Intern Med 47:1387-1394
19. Yoon HI, Silverman EK, Lee HW, Yoo CG, Lee CT, Chung HS et al (2006) Lack of association between COPD and transforming growth factor-beta1 (TGFB1) genetic polymorphisms in Koreans. Int J Tuberc Lung Dis 10:504-509
20. American Thoracic Society (1991) Lung function testing: selection of reference values and interpretative strategies. Am Rev Respir Dis 144:1202-1218
21. Hedayati M, Sharifi K, Rostami F, Daneshpour MS, Zarif Yeganeh M, Azizi F (2012) Association between TNF-α promoter G-308A and G-238A polymorphisms and obesity. Mol Biol Rep 39:825-829
22. Kim HB, Kang MJ, Lee SY, Jin HS, Kim JH, Kim BS et al (2008) Combined effect of tumour necrosis factor-alpha and interleukin-13 polymorphisms on bronchial hyperresponsiveness in Korean children with asthma. Clin Exp Allergy 38:774-780
23. Pinto-Plata V, Casanova C, Müllerova H, de Torres JP, Corado H, Varo N et al (2012) Inflammatory and repair serum biomarker pattern: association to clinical outcomes in COPD. Respir Res 20(13):71. doi: 10.1186/1465-9921-13-71
24. Stoll P, Wuertemberger U, Bratke K, Zingler C, Virchow JC, Lommatzsch M (2012) Stage-dependent association of BDNF and TGF-β1 with lung function in stable COPD. Respir Res 13:116. doi: 10.1186/1465-9921-13-116
25. Kim IY, Kim MM, Kim SJ (2005) Transforming growth factor-beta: biology and clinical relevance [Review]. J Biochem Mol Biol 38:1-8
26. Kenyon NJ, Ward RW, McGrew G, Last JA (2003) TGF-beta1 causes airway fibrosis and increased collagen I and III mRNA in mice. Thorax 58:772-777
27. Takizawa H, Tanaka M, Takami K, Ohtoshi T, Ito K, Satoh M et al (2001) Increased expression of transforming growth factor-beta1 in small airway epithelium from tobacco smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 163:1476-1483
28. Soltani A, Sohal SS, Reid D, Weston S, Wood-Baker R, Walters EH (2012) Vessel-associated transforming growth factor-beta1 (TGF-β1) is increased in the bronchial reticular basement membrane in COPD and normal smokers. PLoS ONE 7:e39736. doi: 10.1371/journal.pone.0039736